C-RAD reports revenue growth and improved profitability
Revenue increased 16% to MSEK 122 and EBIT margin improved to 23%, while order intake decreased 15%.
See the latest news and media coverage for C-RAD. We track all announcements, press releases, and industry mentions in real time, all in one place.
Surface Guided Radiation Therapy provider
c-rad.comLast updated
In short: C-RAD reported strong Q2 2026 results with a 16% revenue increase and improved profitability following the appointment of a new CEO.
Revenue increased 16% to MSEK 122 and EBIT margin improved to 23%, while order intake decreased 15%.
CEO Tomas Blomquist states it marks an important phase with increased pace and prioritization on value drivers.
The meeting approves the accounts, resolves on dividend of 0.10 kr/share, grants discharge of liability, elects board with Thomas Axelsson as chairman and adopts LTIP 2026.
Order intake rose 19% to MSEK 115 while revenue fell 12% to MSEK 105; EBIT improved and a SEK 10m restructuring was recognized.
C-RAD delivered strong revenue and profitability in the second quarter, with sales rising 16 percent to MSEK 122 and EBIT margin improving to 23 percent...
" Performance. Accountability. Execution. The beginning of a new chapter for C-RAD" First quarter January-MarchOrder intake increased 19 percent to MSEK 115 (97) (30 percent...
Latest news in brief - around the clock. Do you have a news tip? Contact Expressen at tipsa@expressen.se or send SMS/MMS to 0790-643 643...
The nomination committee for C-Rad proposes fertility company Vitrolife's former CEO Thomas Axelsson as new board chairman for the medical technology company...
Track C-RAD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to C-RAD and other trending companies.